Novavax Says Omicron BA.1-Tailored COVID-19 Vaccine Shows Strong Immune Response As Fourth Dose

Reuters (11/8, Satija) reports Novavax on Tuesday “said...its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study.” Study data “showed the...